Thrombolytic therapy in acute pulmonary embolism due to heparin-induced thrombocytopenia type II.
Hospitalized patients are in danger of deep venous thrombosis either due to a genetic tendency, immobilization or the underlying medical condition. Paradoxically heparin, the substance used to prevent this complication, can lead to thrombo-embolic phenomena, which can be life threatening. We report a case of heparin-induced thrombocytopenia, which caused a massive pulmonary embolism, and its management by administering a thrombolytic agent in a situation where bleeding seems inevitable.
Alafify
Azza A
AA
Department of Cardiology, Riyadh Medical Complex, Ministry of Health, Kingdom of Saudi Arabia. alafifiazza@hotmail.com
Al-Khuwaitir
Tarig S
TS
Al-Mugheiri
Abdurahman M
AM
Ndao
Djibril M
DM
D000063:Accidents, Traffic; D000208:Acute Disease; D005500:Follow-Up Studies; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009104:Multiple Trauma / Q000175:diagnosis / Q000628:therapy; D049268:Positron-Emission Tomography; D011655:Pulmonary Embolism / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D018570:Risk Assessment; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000150:complications; D015912:Thrombolytic Therapy / Q000009:adverse effects* / Q000379:methods; D016896:Treatment Outcome
D006495:Heparin, Low-Molecular-Weight